1-2 of 2
Jian-Da Hu
Close
Sort by
Journal Articles

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study

Clinical Trials & Observations
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Yu Hu, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zun-Min Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Ren-Bin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4349–4357.
https://doi.org/10.1182/bloodadvances.2022009168
Published: 2023
Includes: Supplemental data
Journal Articles

Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study

Shan Chong, Peng Zhao, Rui-Bin Huang, Hu Zhou, Jia-Ning Zhang, Ming Hou, Yi Liu, Hong-Xia Yao, Ting Niu, Jun Peng, Ming Jiang, Yan-Qiu Han, Jian-Da Hu, Ze-Ping Zhou, Lin Qiu, Lian-Sheng Zhang, Xin Wang, Hua-Quan Wang, Ru Feng, Lin-Hua Yang, Liang-Ming Ma, Shun-Qing Wang, Pei-Yan Kong, Wen-Sheng Wang, Hui-Ping Sun, Jing Sun, He-Bing Zhou, Tie-Nan Zhu, Li-Ru Wang, Jing-Yu Zhang, Qiu-Sha Huang, Hai-Xia Fu, Ye-Jun Wu, Yue-Ying Li, Qian-Fei Wang, Qian Jiang, Hao Jiang, Jin Lu, Xiao-Jun Huang, Xiao-Hui Zhang
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4320–4329.
https://doi.org/10.1182/bloodadvances.2022007226
Published: 2022
Includes: Supplemental data